Emerging treatment modalities for systemic therapy in hepatocellular carcinoma

Emerging treatment modalities for systemic therapy in hepatocellular carcinoma

Abstract Hepatocellular carcinoma (HCC) has long been a major global clinical problem as one of the most common malignant tumours with a high rate of recurrence and mortality. Although potentially curative therapies are available for the early and intermediate stages, the treatment of patients with...

Full description

Bibliographic Details
Main Authors: Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Biomarker Research
Subjects:
Hepatocellular carcinoma
Targeted therapy
Immunotherapy
Tyrosine kinase inhibitors
Immune checkpoint inhibitors
Signalling pathway
Online Access:https://doi.org/10.1186/s40364-021-00319-3

Similar Items

Similar Items